Womturn I Suspension contains Ivermectin 3mg + Albendazole 200mg, a well-established combination used in the treatment of intestinal parasitic and worm infestations. It is commonly prescribed for roundworms, hookworms, threadworms, and mixed helminthic infections in pediatric and adult patients.
Albendazole works by inhibiting parasite glucose uptake, leading to energy depletion and death of worms, while Ivermectin enhances antiparasitic action by causing paralysis of parasites. This dual-action approach improves treatment efficacy and reduces recurrence risk.
The suspension form ensures ease of administration, accurate dosing, and better patient compliance, especially in children. Due to its wide clinical acceptance and routine use in deworming programs, this combination maintains consistent market demand.
Adding Womturn I Suspension to your anthelmintic and antiparasitic segment strengthens your portfolio with a high-rotation product. Its broad therapeutic application, prescriber trust, and export suitability make it a strong choice for PCD pharma companies, distributors, and third-party manufacturing partners.